Posts for Ticker ‘XTLB’

The 52-Week Low Club (SIRI)(GM)(C)(CIT)(SKS)(XTLB)

Sad_clownSirius (SIRI) traded down to $.20 on concern that a bankruptcy at GM (GM) could ruin its already troubled business. The 52-week high is $2.94.

Citigroup (C) Still concerns that bank can hold off a government rescue due to consumer debt balance sheet issues. Drops to $7.89 from 52-week high of $35.29.

CIT Group (CIT) Analyst said CIT’s ability to become a commercial bank is critical to its future. What it it does not work out? Drops to $2.43 from 52-week high of $30.75.

Saks (SKS) Bad earnings, concern about debt. Down to $2.71 from 52-week high of $22.19.

Xtl Biopharmaceuticals (XTLB) Important drug fails trial and analyst downgrade. The daily double. Falls to $.11 from 52-week high of $4.96.

Douglas A. McIntyre

New Biotech Zombie: XTL Biopharma (XTLB)

BurningmoneyXTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) is an Israeli biotech player that most traders have not heard of.  By the looks of the trading today, it doesn’t look like shareholders will get to hear about it for too much longer either.  The company stumbled on a Phase II test, and that may be all she wrote.

Read More »